Current and Emerging Methods of Management of Ependymoma.


Journal

Current oncology reports
ISSN: 1534-6269
Titre abrégé: Curr Oncol Rep
Pays: United States
ID NLM: 100888967

Informations de publication

Date de publication:
29 07 2019
Historique:
entrez: 31 7 2019
pubmed: 31 7 2019
medline: 25 8 2020
Statut: epublish

Résumé

This review discusses the evidence base behind current and emerging strategies of management of intracranial and spinal ependymomas in children, with a particular focus on aspects of surgical techniques, challenges and complications. The cornerstone of management remains maximal safe resective surgery, which has repeatedly been shown to correlate with improved survival. This is followed by focal conformal radiotherapy, although good results using proton beam therapy, with the potential for diminished side effects, are emerging. The role of chemotherapy remains largely unproven for paediatric ependymoma. Despite optimal management strategies, many children with ependymoma suffer from tumour recurrence. The standard of care for paediatric ependymoma comprises surgery and radiotherapy. Results of ongoing clinical trials will help shape its management in order to leverage our increasingly sophisticated understanding of the genetic drivers behind these tumours into survival benefit for this challenging group of patients.

Identifiants

pubmed: 31359299
doi: 10.1007/s11912-019-0826-y
pii: 10.1007/s11912-019-0826-y
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

78

Subventions

Organisme : Department of Health
Pays : United Kingdom

Références

Am J Pathol. 1999 Aug;155(2):627-32
pubmed: 10433955
J Clin Oncol. 2001 Mar 1;19(5):1288-96
pubmed: 11230470
Am J Clin Oncol. 2002 Apr;25(2):117-22
pubmed: 11943886
J Clin Oncol. 2004 Aug 1;22(15):3156-62
pubmed: 15284268
Radiother Oncol. 2005 Dec;77(3):278-85
pubmed: 16300848
J Neurosurg. 2007 Apr;106(4 Suppl):261-7
pubmed: 17465358
Cancer. 2007 Jul 15;110(2):432-41
pubmed: 17559078
Lancet Oncol. 2007 Aug;8(8):696-705
pubmed: 17644039
Cancer. 2007 Oct 1;110(7):1542-50
pubmed: 17705175
Mod Pathol. 2008 Feb;21(2):165-77
pubmed: 18084249
Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):87-97
pubmed: 18406885
J Neurosurg. 2009 Apr;110(4):725-9
pubmed: 19061350
Lancet Oncol. 2009 Mar;10(3):258-66
pubmed: 19274783
J Neurooncol. 2009 Sep;94(3):391-8
pubmed: 19330288
Childs Nerv Syst. 2009 Oct;25(10):1249-52
pubmed: 19337738
Childs Nerv Syst. 2009 Oct;25(10):1293-301
pubmed: 19360417
Eur J Cancer. 2009 Jul;45(10):1815-23
pubmed: 19427780
Childs Nerv Syst. 2009 Oct;25(10):1283-91
pubmed: 19484246
Childs Nerv Syst. 2009 Oct;25(10):1229-40
pubmed: 19484252
J Neurosurg Pediatr. 2009 Nov;4(5):467-74
pubmed: 19877782
Childs Nerv Syst. 2010 Jul;26(7):905-11
pubmed: 20039045
J Neurosurg Pediatr. 2010 Aug;6(2):137-44
pubmed: 20672934
J Neurooncol. 2011 Jul;103(3):693-8
pubmed: 21038109
J Neurosurg Pediatr. 2010 Nov;6(5):417-23
pubmed: 21039163
J Negat Results Biomed. 2011 May 31;10:7
pubmed: 21627842
J Neurooncol. 2011 Dec;105(3):583-90
pubmed: 21637963
J Neurooncol. 2012 Jan;106(2):367-75
pubmed: 21826561
Cancer Cell. 2011 Aug 16;20(2):143-57
pubmed: 21840481
J Neurosurg Pediatr. 2011 Sep;8(3):246-50
pubmed: 21882914
J Clin Oncol. 2012 Jul 10;30(20):2559-65
pubmed: 22529254
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):421-7
pubmed: 22713833
Pediatr Blood Cancer. 2012 Dec 15;59(7):1183-9
pubmed: 22949057
Childs Nerv Syst. 2012 Dec;28(12):2017-28
pubmed: 22961356
Neuro Oncol. 2013 Feb;15(2):208-15
pubmed: 23229996
J Neurooncol. 2013 May;113(1):39-48
pubmed: 23462854
J Neurooncol. 2013 Jun;113(2):285-91
pubmed: 23508296
J Neurosurg Pediatr. 2013 Jun;11(6):673-81
pubmed: 23540528
J Neurooncol. 2014 Jan;116(1):107-11
pubmed: 24078173
Neuro Oncol. 2013 Nov;15(11):1552-9
pubmed: 24101739
J Neurosurg Pediatr. 2014 Apr;13(4):393-9
pubmed: 24506340
Pediatr Blood Cancer. 2014 Jul;61(7):1195-201
pubmed: 24615997
AJNR Am J Neuroradiol. 2014 Dec;35(12):2382-7
pubmed: 25059696
Pediatr Neurosurg. 2015;50(2):68-72
pubmed: 25871983
Cancer Cell. 2015 May 11;27(5):728-43
pubmed: 25965575
Neurosurg Focus. 2015 Aug;39(2):E8
pubmed: 26235025
Radiother Oncol. 2015 Aug;116(2):301-8
pubmed: 26243681
Neuro Oncol. 2016 Feb;18(2):261-8
pubmed: 26323606
Childs Nerv Syst. 2015 Oct;31(10):1791-806
pubmed: 26351231
Neuro Oncol. 2016 Oct;18(10):1451-60
pubmed: 27194148
J Clin Oncol. 2016 Jul 20;34(21):2468-77
pubmed: 27269943
Childs Nerv Syst. 2016 Nov;32(11):2189-2196
pubmed: 27585992
J Neurosurg Pediatr. 2017 Jan;19(1):77-84
pubmed: 27791707
Acta Neuropathol. 2017 Jan;133(1):5-12
pubmed: 27858204
Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):216-219
pubmed: 28068228
Cancer. 2017 Jul 1;123(13):2570-2578
pubmed: 28267208
Neuro Oncol. 2018 Mar 27;20(4):445-456
pubmed: 29194500
Int J Radiat Oncol Biol Phys. 2018 Feb 01;100(2):507-515
pubmed: 29229328
Acta Oncol. 2018 May;57(5):644-648
pubmed: 29239262
Childs Nerv Syst. 2018 Apr;34(4):617-626
pubmed: 29460065
Neurosurgery. 2019 Mar 1;84(3):636-646
pubmed: 29617945
Neuro Oncol. 2019 Mar 18;21(4):547-557
pubmed: 30452715
Childs Nerv Syst. 2019 Mar;35(3):411-420
pubmed: 30554263
Clin Oncol (R Coll Radiol). 2019 Mar;31(3):162-170
pubmed: 30616927
Neuro Oncol. 2019 May 6;21(5):678-685
pubmed: 30624746
Cancer. 2019 Jun 1;125(11):1867-1876
pubmed: 30768777
Int J Radiat Oncol Biol Phys. 1994 Jan 15;28(2):381-6
pubmed: 8276653
N Engl J Med. 1993 Jun 17;328(24):1725-31
pubmed: 8388548
Neurosurgery. 1997 Apr;40(4):856-60; discussion 860
pubmed: 9092863
Med Pediatr Oncol. 1997 Aug;29(2):79-85
pubmed: 9180907

Auteurs

Sebastian M Toescu (SM)

Developmental Imaging and Biophysics Section, UCL-GOS Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.
Department of Neurosurgery, Great Ormond Street Hospital for Children, London, WC1N 3JH, UK.

Kristian Aquilina (K)

Department of Neurosurgery, Great Ormond Street Hospital for Children, London, WC1N 3JH, UK. Kristian.aquilina@gosh.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH